Large-scale testing (Phase 3)Ended earlyNCT00089141What this trial is testingMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)Who this might be right forCancer Martin, Paul 151
Not applicableStudy completedNCT05260203What this trial is testingMargheRITA (Remote Intelligence for Therapeutic Adherence)Who this might be right forMultiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more Advice Pharma Group srl 124
Testing effectiveness (Phase 2)Study completedNCT00006373What this trial is testingCombination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's LymphomaWho this might be right forLymphoma H. Lee Moffitt Cancer Center and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT00002673What this trial is testingImmunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 30
Not applicableLooking for participantsNCT06475469What this trial is testingDescription of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious RiskWho this might be right forChronic Lymphocytic Leukemia CHU de Reims 75
Large-scale testing (Phase 3)Looking for participantsNCT04269902What this trial is testingTesting Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL StudyWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma National Cancer Institute (NCI) 247
Early research (Phase 1)UnknownNCT03823365What this trial is testingBlinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic LeukemiaWho this might be right forIndolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia A.O. Ospedale Papa Giovanni XXIII 19
Early research (Phase 1)UnknownNCT02968472What this trial is testingA Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell LeukemiaWho this might be right forB Acute Lymphoblastic Leukemia The First People's Hospital of Yunnan 30
Very early researchStudy completedNCT03771157What this trial is testingSerologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK InhibitorsWho this might be right forChronic Lymphocytic Leukemia (CLL)Waldenstrom Macroglobulinemia (WM) University of Rochester 33
Early research (Phase 1)Looking for participantsNCT04892277What this trial is testingCD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell MalignanciesWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+5 more Mayo Clinic 25
Testing effectiveness (Phase 2)Study completedNCT00283101What this trial is testingA Safety Study in Patients With Chronic Lymphocytic LeukemiaWho this might be right forLeukemia, Lymphocytic, Chronic Seagen Inc. 12
Not applicableStudy completedNCT00577798What this trial is testingCardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving DoxorubicinWho this might be right forCardiac ToxicityChemotherapeutic Agent ToxicityLymphoma University of Nebraska 10
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Early research (Phase 1)Study completedNCT00005092What this trial is testingChemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more M.D. Anderson Cancer Center 7
Early research (Phase 1)Study completedNCT00019344What this trial is testingFlavopiridol in Treating Patients With Refractory CancerWho this might be right forLymphomaProstate CancerSmall Intestine Cancer+1 more National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT03463928What this trial is testingA Feasibility and Safety Study of Concomitant Therapy With Allo-CAR-T Cells and Allo-HSCT in Patients With Relapse or Refractory LeukemiaWho this might be right forB Cell Leukemia Chinese PLA General Hospital 10
Early research (Phase 1)Ended earlyNCT00005787What this trial is testingPeripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaNeutropenia Northwestern University 3
Not applicableUnknownNCT05803395What this trial is testingIncidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.Who this might be right forChronic Lymphocytic LeukemiaIndolent B-Cell Non-Hodgkin LymphomaCOVID-19 Gruppo Italiano Malattie EMatologiche dell'Adulto 954
Testing effectiveness (Phase 2)Ended earlyNCT00151736What this trial is testingSafety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Cephalon 88
Testing effectiveness (Phase 2)Study completedNCT00349349What this trial is testingHuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and AlemtuzumabWho this might be right forLeukaemia, Lymphocytic, Chronic GlaxoSmithKline 223